Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults
Public ClinicalTrials.gov record NCT00527046. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind, Placebo Controlled, Five Parallel Group Study Of The Effect Of CP-424,391 On Physical Performance And Body Composition In Older Subjects
Study identification
- NCT ID
- NCT00527046
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 396 participants
Conditions and interventions
Conditions
Interventions
- CP-424,391 Drug
Drug
Eligibility (public fields only)
- Age range
- 65 Years to 84 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 1999
- Primary completion
- Sep 30, 2001
- Completion
- Sep 30, 2001
- Last update posted
- Feb 1, 2012
1999 – 2001
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Palo Alto | California | — | — |
| Pfizer Investigational Site | San Diego | California | — | — |
| Pfizer Investigational Site | Hamden | Connecticut | — | — |
| Pfizer Investigational Site | New Britain | Connecticut | — | — |
| Pfizer Investigational Site | Lake Worth | Florida | — | — |
| Pfizer Investigational Site | Baltimore | Maryland | — | — |
| Pfizer Investigational Site | Boston | Massachusetts | — | — |
| Pfizer Investigational Site | Rochester | New York | — | — |
| Pfizer Investigational Site | Durham | North Carolina | — | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00527046, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 1, 2012 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00527046 live on ClinicalTrials.gov.